Los Angeles Capital Management
ATRA icon

Los Angeles Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

Los Angeles Capital Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-980
Closed -$438K – 1393
2021
Q3 		$438K Sell
980
-1,880
-66% -$674K ﹤0.01% 1116
2021
Q2 		$1.11M Sell
2,860
-176
-6% -$62.8K ﹤0.01% 811
2021
Q1 		$1.09M Buy
3,036
+1,003
+49% +$443K ﹤0.01% 856
2020
Q4 		$998K Buy
2,033
+235
+13% +$108K ﹤0.01% 948
2020
Q3 		$583K Buy
1,798
+54
+3% +$18.4K ﹤0.01% 1023
2020
Q2 		$635K Buy
1,744
+1,286
+281% +$325K ﹤0.01% 1020
2020
Q1 		$97K Buy
+458
New +$145K ﹤0.01% 1298

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return